To verify whether NR2F1-AS1 regulates NSCLC progression by modulating miR-363-3p expression, the sh-NR2F1-AS1 and miR-363-3p inhibitors were cotransfected into cells. Here, NR2F1 is linked to non-small cell lung carcinoma.